Publication

Method of preparation of amyloidogenic protein aggregates and uses thereof

Related publications (40)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Method of preparation of amyloidogenic protein aggregates and uses thereof

Graph Chatbot

Chat with Graph Search

Deconstructing and Reconstructing the Complexity of Tau pathology

Trans‐seeding of Alzheimer‐related tau protein by a yeast prion

Structural strains of misfolded tau protein define different diseases

Neurodegeneration Structural strains of tau protein classify diseases

To target Tau pathologies, we must embrace and reconstruct their complexities

Rethinking protein aggregation and drug discovery in neurodegenerative diseases: Why we need to embrace complexity?

Anti-Aβ antibodies bound to neuritic plaques enhance microglia activity and mitigate tau pathology

Gold nanoparticles as a new tool in amyloid studies

Unraveling the complexity of amyloid polymorphism using gold nanoparticles and cryo-EM

Discovery of 2-(4-(2-fluoroethoxy)piperidin-1-yl)-9-methyl-9H-pyrrolo[2,3-b:4,5-c']dipyridine ([18F]PI-2014) as PET tracer for the detection of pathological aggregated tau in Alzheimer's disease and other tauopathies